Published in Lancet on February 20, 1999
Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg (2003) 2.80
Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid (2010) 1.33
A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer (2011) 1.21
Does familial non-medullary thyroid cancer adversely affect survival? World J Surg (2006) 1.15
An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg (2007) 1.14
The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid (2012) 1.08
Familial papillary thyroid carcinoma: a retrospective analysis. J Oncol (2011) 1.04
Hereditary non-medullary thyroid cancer. World J Surg (2008) 0.97
MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One (2011) 0.94
Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure. World J Surg (2012) 0.94
Pediatric thyroid carcinoma incidence and temporal trends in the USA (1973-2007): race or shifting diagnostic paradigm? ISRN Oncol (2012) 0.90
Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation. Langenbecks Arch Surg (2010) 0.89
Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2004) 0.86
Familial papillary thyroid microcarcinoma. Lancet (1999) 0.86
Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital. J Thyroid Res (2011) 0.84
Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma. World J Surg (2004) 0.84
Population-based study of familial medullary thyroid cancer. Fam Cancer (2001) 0.81
Clinicopathologic characteristics of familial versus sporadic papillary thyroid carcinoma. Acta Otorhinolaryngol Ital (2015) 0.77
Controversies in familial thyroid cancer 2014. Ulus Cerrahi Derg (2014) 0.76
Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases. World J Surg (2015) 0.76
Association between rs12045440 Polymorphism in the CAPZB Intron and Serum TSH Concentrations in Chinese Thyroid Tumor Patients. Int J Endocrinol (2015) 0.76
Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families. Front Endocrinol (Lausanne) (2015) 0.76
Running in the family: A rare diagnosis of familial papillary thyroid cancer. Int J Surg Case Rep (2015) 0.76
Is familial papillary thyroid microcarcinoma more aggressive than sporadic form? Ann Surg Treat Res (2017) 0.75
Incidental and non-incidental thyroid microcarcinoma. Oncol Lett (2016) 0.75
Retrospective Analysis of 255 Papillary Thyroid Carcinomas ≤2 cm: Clinicohistological Features and Prognostic Factors. Eur Thyroid J (2014) 0.75
Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell (1995) 4.39
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer Res (2000) 3.95
Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett (1999) 3.00
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res (2001) 2.29
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer (2003) 2.26
Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA (1993) 2.21
Hydrogen peroxide-related colitis (previously known as "pseudolipomatosis"): a series of cases occurring in an epidemic pattern. Endoscopy (2007) 2.07
Psoas compartment block for anaesthesia during surgical repair of inguinal hernias. Br J Anaesth (2013) 1.99
Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man. Proc Natl Acad Sci U S A (1975) 1.83
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Clin Cancer Res (2000) 1.82
Comparison of two methods for weaning patients with chronic obstructive pulmonary disease requiring mechanical ventilation for more than 15 days. Am J Respir Crit Care Med (2001) 1.75
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. J Clin Oncol (1996) 1.74
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Clin Cancer Res (1999) 1.66
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer (2005) 1.61
Pre- and postoperative intra-articular analgesia for arthroscopic surgery of the knee and arthroscopy-assisted anterior cruciate ligament reconstruction. A double-blind randomized, prospective study. Knee Surg Sports Traumatol Arthrosc (1997) 1.57
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res (1998) 1.54
Deoxyhypusine hydroxylase from rat testis. Partial purification and characterization. J Biol Chem (1986) 1.44
The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article. Amino Acids (2004) 1.44
[Prevalence of inapropriate LDL cholesterol levels in patients with coronary disease and/or type 2 diabetes]. Rev Clin Esp (2012) 1.41
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis (2012) 1.40
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells. Leukemia (2011) 1.38
Vertical gradient of regional lung inflation in adult respiratory distress syndrome. Am J Respir Crit Care Med (1994) 1.32
Body position changes redistribute lung computed-tomographic density in patients with acute respiratory failure. Anesthesiology (1991) 1.29
Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages. Int J Med Microbiol (2000) 1.27
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? Eur J Cancer (1996) 1.26
The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis. Amino Acids (2001) 1.26
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer (2003) 1.21
Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase. Curr Drug Targets (2005) 1.21
Epidemiology of boutonneuse fever in western Sicily. Distribution and prevalence of spotted fever group rickettsial infection in dog ticks (Rhipicephalus sanguineus). Am J Epidemiol (1986) 1.21
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis (2011) 1.18
Goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer (1992) 1.17
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells. Mol Carcinog (1992) 1.17
The heart: an end-organ of GH action. Eur J Endocrinol (2004) 1.16
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis (2011) 1.14
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst (1996) 1.13
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ (1999) 1.13
In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis. Cytokine (1995) 1.13
Percutaneous aspiration biopsy of the pancreas under ultrasonic guidance. N Engl J Med (1975) 1.12
Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther (1997) 1.11
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol (1996) 1.10
Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways. Curr Drug Targets (2005) 1.10
Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects. J Hypertens (1999) 1.10
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways. Curr Cancer Drug Targets (2009) 1.10
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer. Br J Cancer (2006) 1.09
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells. Cell Prolif (2012) 1.09
The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J Biochem (2003) 1.09
eIF5A isoforms and cancer: two brothers for two functions? Amino Acids (2011) 1.09
The role of the surgeon in the evolution of flexible endoscopy. Surg Endosc (2006) 1.09
WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep (2010) 1.09
Acetylation of proteins as novel target for antitumor therapy: review article. Amino Acids (2004) 1.08
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology (1997) 1.07
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment. Hum Reprod (2005) 1.05
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy. Cell Death Dis (2012) 1.05
Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid (2002) 1.04
Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications. Curr Drug Targets (2005) 1.03
Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. Clin Cancer Res (2000) 1.02
Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines. Leukemia (2000) 1.02
Immunopathology of leishmaniasis: an update. Int J Immunopathol Pharmacol (2007) 1.01
C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A. Cell Death Differ (2007) 1.01
The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene (1997) 1.00
Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol (2002) 1.00
Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer (1996) 0.99
Numerical/experimental analysis of the stress field around miniscrews for orthodontic anchorage. Eur J Orthod (2008) 0.99
Interferon alpha-2b at low doses as long-term antiangiogenic treatment of a metastatic intracranial hemangioendothelioma: a case report. Oncol Rep (2000) 0.99
Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma. Curr Cancer Drug Targets (2012) 0.97
Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro. Int J Cancer (2011) 0.97
Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A). Protein Eng (2001) 0.97
Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer (2001) 0.97
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. Int J Pharm (2010) 0.97
Deregulation of HOX B13 expression in urinary bladder cancer progression. Curr Med Chem (2013) 0.96
Survival data relating to the use of goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer (1993) 0.96
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells. Cell Death Dis (2013) 0.95
Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother Res (2003) 0.94
Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study. Br J Cancer (2000) 0.94